Medline Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	1.67
Debt / Equity	1.00
Debt / EBITDA	5.06
Debt / FCF	15.22
Interest Coverage	2.57

Financial Efficiency

Return on equity (ROE) is 7.65% and return on invested capital (ROIC) is 6.50%.

Return on Equity (ROE)	7.65%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.50%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$620,977
Profits Per Employee	$2.12M
Employee Count	43,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Medline has paid $72.00 million in taxes.

Income Tax	72.00M
Effective Tax Rate	0.08%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medline had revenue of $26.70 billion and earned $91.30 billion in profits.

Revenue	26.70B
Gross Profit	7.34B
Operating Income	2.28B
Pretax Income	1.34B
Net Income	91.30B
EBITDA	3.28B
EBIT	2.20B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $580.00 million in cash and $16.58 billion in debt, giving a net cash position of -$16.00 billion.

Cash & Cash Equivalents	580.00M
Total Debt	16.58B
Net Cash	-16.00B
Net Cash Per Share	n/a
Equity (Book Value)	16.58B
Book Value Per Share	n/a
Working Capital	6.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.53 billion and capital expenditures -$439.00 million, giving a free cash flow of $1.09 billion.

Operating Cash Flow	1.53B
Capital Expenditures	-439.00M
Free Cash Flow	1.09B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.48%, with operating and profit margins of 8.53% and 341.91%.

Gross Margin	27.48%
Operating Margin	8.53%
Pretax Margin	5.02%
Profit Margin	341.91%
EBITDA Margin	12.28%
EBIT Margin	8.22%
FCF Margin	4.08%

Dividends & Yields

Medline does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a